Evidence map›Paper›PMID 41955026›Full record

ArticleBriefings in bioinformatics2026

Addressing biases and limitations in feature attribution for circRNA modification profiling.

Souichi Oka, Kota Takemura, Yoshiyasu Takefuji

Abstract read
In one paragraph

Article in Briefings in bioinformatics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Souichi OkaResearch and Development Planning Department, Science Park Corporation, 3-24-9 Iriya-Nishi, Zama-shi, Kanagawa 252-0029, Japan.ORCID 0009-0000-4840-5232
Kota TakemuraResearch and Development Planning Department, Science Park Corporation, 3-24-9 Iriya-Nishi, Zama-shi, Kanagawa 252-0029, Japan.ORCID 0009-0000-5890-8087
Yoshiyasu TakefujiDepartment of Data Science, Faculty of Data Science, Musashino University, 3-3-3 Ariake Koto-ku, Tokyo 135-8181, Japan.ORCID 0000-0002-1826-742X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Li et al. (CircRM: Profiling circular RNA modifications from nanopore direct RNA sequencing. Brief Bioinform 2026;27:bbaf726.) introduced Circular RNA Modifications (CircRM), a computational framework employing eXtreme Gradient Boosting and SHapley Additive exPlanations (SHAP) to profile RNA modifications in circular RNAs, achieving high predictive accuracy. However, we argue that strong predictive performance does not validate the biological reliability of the resulting feature-importance rankings. In heterogeneous feature spaces, tree-based models exhibit inherent biases, favoring continuous, high-cardinality variables-such as genomic position-over sparse sequence patterns, potentially obscuring true biological determinants. Furthermore, reliance on SHAP introduces theoretical vulnerabilities; recent findings on attribution limitations indicate that baseline sensitivity can decouple explanations from local mechanistic behavior. To address these analytical pitfalls, we advocate for a robust framework incorporating Highly Variable Gene Selection and Feature Agglomeration to mitigate multicollinearity, complemented by model-agnostic non-parametric methods such as Spearman's rho and Kendall's tau. Adopting these strategies ensures that computational profiling yields biologically actionable insights rather than reflecting statistical artifacts.

Indexed as

Computational BiologyRNA, CircularHumansSequence Analysis, RNARNA, CircularcircularRNAepitranscriptomicsfeature importancemachine learningmodel bias

Identifiers

PMID41955026
PMCPMC13069895

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.